Janux announces doses selected for phase 1b expansion trials supported by encouraging efficacy and safety profile observed in phase 1a dose escalation for janx007 in mcrpc

San diego--(business wire)---- $janx--janux announces efficacy and safety profile observed in phase 1a dose escalation for janx007 in mcrpc.

JANX Ratings Summary

JANX Quant Ranking